MetLife Investment Management’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-43,070
Closed -$78.4K 3005
2023
Q1
$78.4K Sell
43,070
-17,098
-28% -$37.2K ﹤0.01% 2646
2022
Q4
$125K Hold
60,168
﹤0.01% 2500
2022
Q3
$181K Hold
60,168
﹤0.01% 2360
2022
Q2
$193K Buy
+60,168
New +$326K ﹤0.01% 2346

Other funds holding HLTH

MetLife Investment Management's HLTH Position: Q2 2023 in Review

MetLife Investment Management sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2023, closing a stake of 43,070 shares — an estimated $78.4K sold.

MetLife Investment Management first reported a position in HLTH in Q2 2022 and held it in 4 quarters. The position peaked at $193K in Q2 2022. 79 funds tracked by Wall St. Rank hold HLTH as of Q2 2023.

  • MetLife Investment Management reported no remaining Cue Health Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • MetLife Investment Management sold 43,070 Cue Health Inc. Common Stock shares in Q2 2023, an estimated $78.4K.
  • MetLife Investment Management first reported a position in Cue Health Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • MetLife Investment Management's Cue Health Inc. Common Stock position peaked at $193K in Q2 2022.
  • 79 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2023.

Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.